The future of genomics
Our hope for the future is to find the right treatment, for example the right drug, at the right dosage, from the point of diagnosis. Genomic medicine has the potential to transform the way we care for people with epilepsy, and we believe that whole genome sequencing will help us to unravel the genetic architecture underlying the different types of epilepsy.
We hope it will help us determine the cause of a person’s seizures, their response to anti-epileptic medication and their susceptibility to Sudden Unexpected Death in Epilepsy (SUDEP), and that this will enable us to prescribe more personalised, targeted treatments and reduce the burden that epilepsy places on many people’s lives.
Dr Krithika Iyer Sundararaman, postdoctoral research fellow, using whole exome sequencing technology to read DNA at Epilepsy Society's Chalfont Centre (pictured right).